LifeTech Scientific Corporation
HKEX:1302.HK
1.41 (HKD) • At close September 16, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) HKD.
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue
| 1,267.175 | 1,097.31 | 925.334 | 642.299 | 668.879 | 556.698 | 409.125 | 352.849 | 311.606 | 282.679 | 231.035 | 181.475 | 140.324 | 104.704 |
| Cost of Revenue
| 271.538 | 223.382 | 177.8 | 129.154 | 134.059 | 101.677 | 77.168 | 76.315 | 59.03 | 52.544 | 42.399 | 36.175 | 27.357 | 21.066 |
| Gross Profit
| 995.637 | 873.928 | 747.534 | 513.145 | 534.82 | 455.021 | 331.957 | 276.534 | 252.576 | 230.135 | 188.636 | 145.3 | 112.967 | 83.638 |
| Gross Profit Ratio
| 0.786 | 0.796 | 0.808 | 0.799 | 0.8 | 0.817 | 0.811 | 0.784 | 0.811 | 0.814 | 0.816 | 0.801 | 0.805 | 0.799 |
| Reseach & Development Expenses
| 297.921 | 208.481 | 145.886 | 167.274 | 141.112 | 115.2 | 62.201 | 57.525 | 47.222 | 33.308 | 31.039 | 23.608 | 22.762 | 15.442 |
| General & Administrative Expenses
| 149.251 | 102.478 | 97.022 | 104.107 | 132.395 | 95.345 | 52.946 | 51.621 | 47.567 | 75.671 | 63.221 | 37.898 | 44.88 | 16.953 |
| Selling & Marketing Expenses
| 265.339 | 245.222 | 194.153 | 216.373 | 166.468 | 129.633 | 84.772 | 81.574 | 73.6 | 69.083 | 52.123 | 41.221 | 34.552 | 20.057 |
| SG&A
| 414.59 | 347.7 | 291.175 | 320.48 | 298.863 | 224.978 | 137.718 | 133.195 | 121.167 | 144.754 | 115.344 | 79.119 | 79.432 | 37.01 |
| Other Expenses
| -179.123 | -25.233 | -16.197 | -15.694 | -27.112 | 35.252 | 10.548 | 1.259 | 1.291 | 1.032 | 1.203 | 1.218 | -5.018 | -3.333 |
| Operating Expenses
| 701.179 | 530.948 | 420.864 | 472.06 | 412.863 | 337.434 | 144.894 | 175.844 | 159.689 | 173.518 | 141.193 | 96.343 | 97.176 | 49.119 |
| Operating Income
| 383.278 | 368.434 | 328.739 | 70.67 | 188.755 | 164.189 | 192.207 | 108.305 | 94.452 | 49.784 | 42.205 | 48.957 | 15.791 | 34.519 |
| Operating Income Ratio
| 0.302 | 0.336 | 0.355 | 0.11 | 0.282 | 0.295 | 0.47 | 0.307 | 0.303 | 0.176 | 0.183 | 0.27 | 0.113 | 0.33 |
| Total Other Income Expenses Net
| -207.697 | 9.612 | 4.189 | 171.954 | -17.944 | 2.999 | 1.416 | 78.645 | -48.171 | -117.595 | -95.398 | -7.274 | 3.288 | -24.107 |
| Income Before Tax
| 175.581 | 378.046 | 332.928 | 242.624 | 170.811 | 167.188 | 193.623 | 186.95 | 26.396 | -67.811 | -53.193 | 41.683 | 19.079 | 10.412 |
| Income Before Tax Ratio
| 0.139 | 0.345 | 0.36 | 0.378 | 0.255 | 0.3 | 0.473 | 0.53 | 0.085 | -0.24 | -0.23 | 0.23 | 0.136 | 0.099 |
| Income Tax Expense
| 68.091 | 59.307 | 49.571 | 35.581 | 43.647 | 45.835 | 30.049 | 41.24 | 22.371 | 12.921 | 12.187 | 8.821 | 6.517 | 6.621 |
| Net Income
| 263.242 | 325.337 | 292.472 | 216.085 | 129.2 | 121.082 | 163.472 | 145.652 | 2.359 | -81.244 | -65.666 | 32.352 | 11.83 | 3.936 |
| Net Income Ratio
| 0.208 | 0.296 | 0.316 | 0.336 | 0.193 | 0.218 | 0.4 | 0.413 | 0.008 | -0.287 | -0.284 | 0.178 | 0.084 | 0.038 |
| EPS
| 0.06 | 0.077 | 0.068 | 0.05 | 0.031 | 0.028 | 0.038 | 0.036 | 0.001 | -0.02 | -0.016 | 0.008 | 0.004 | 0.002 |
| EPS Diluted
| 0.059 | 0.074 | 0.064 | 0.049 | 0.031 | 0.028 | 0.038 | 0.036 | 0.001 | -0.02 | -0.016 | 0.008 | 0.002 | 0.002 |
| EBITDA
| 216.698 | 497.071 | 440.212 | 133.298 | 227.444 | 204.125 | 211.252 | 120.096 | 82.339 | 59.192 | 48.53 | 56.281 | 22.181 | 39.217 |
| EBITDA Ratio
| 0.171 | 0.453 | 0.476 | 0.208 | 0.34 | 0.367 | 0.516 | 0.34 | 0.264 | 0.209 | 0.21 | 0.31 | 0.158 | 0.375 |